Orally taken hemostatic Chinese medicine


Application Number: 00103088
Application Date: 2000.02.24
Publication Number: 1309982
Publication Date: 2001.08.29
Priority Information:
International: A61K35/60;A61K35/78;A61P7/04
Applicant(s) Name: Sun Xueli
Address:
Inventor(s) Name: Sun Xueli
Patent Agency Code: 00000
Patent Agent:
Abstract The oral hemostatic Chinese medicine consists of Astragalus membranaceus 24-36 wt%, Chinese angelica root 10-20 wt%, prepared remannia rhizome 10-20 w, fish swim-bladder gelatin 8-36 wt%, Taiwan beautyberry leaf 6-12 wt% and honey fried licorice 6-12 wt%. It is used mainly for treating intractable functional womb hemorrhage, and other hemorrhage incapable of being cured with conventional hemostatic. It has obvious cure effect, no toxic side effect and no relapse.